ストックスクリーナーアプリを入手
1.23
7.89%
0.09
アフターアワーズ：
1.23
前日終値:
$1.14
開ける：
$1.16
24時間の取引高:
90,656
Relative Volume:
0.50
時価総額：
$69.62M
収益：
-
当期純損益:
$-131.52M
株価収益率:
-0.691
EPS:
-1.78
ネットキャッシュフロー:
$-107.56M
1週間 パフォーマンス:
+1.65%
1か月 パフォーマンス:
+46.20%
6か月 パフォーマンス:
+62.91%
1年 パフォーマンス:
-74.43%
1日の値動き範囲:
$1.1357
$1.23
1週間の範囲:
$1.1042
$1.255
52週間の値動き範囲:
$0.6101
$5.53
Prelude Therapeutics Inc Stock (PRLD) Company Profile
名前
Prelude Therapeutics Inc
セクター
電話
(302) 467-1280
住所
175 INNOVATION BOULEVARD, WILMINGTON
PRLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRLD
Prelude Therapeutics Inc
|
1.23 | 64.52M | 0 | -131.52M | -107.56M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-20 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2024-03-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-02-20 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-19 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-29 | 開始されました | Jefferies | Buy |
| 2022-03-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-02-28 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-10-08 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-04-26 | 開始されました | H.C. Wainwright | Buy |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2020-11-20 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Goldman | Neutral |
| 2020-10-20 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Prelude Therapeutics Inc (PRLD) 最新ニュース
Published on: 2025-09-06 20:49:10 - Newser
What’s next for Prelude Therapeutics Incorporated stock priceMarket Risk Report & AI Enhanced Execution Alerts - Newser
Published on: 2025-09-06 13:48:12 - Newser
Is Prelude Therapeutics Incorporated showing signs of accumulation2025 Analyst Calls & Weekly High Return Forecasts - Newser
Can Prelude Therapeutics Incorporated stock double in the next yearQuarterly Earnings Summary & Consistent Income Trade Recommendations - خودرو بانک
Is Prelude Therapeutics Incorporated still worth holding after the dipQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
What are Prelude Therapeutics Incorporated’s recent SEC filings showingTrade Exit Summary & Safe Capital Preservation Plans - خودرو بانک
Will Prelude Therapeutics Incorporated continue its uptrend2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
What’s the RSI of Prelude Therapeutics Incorporated stock2025 Short Interest & Weekly High Momentum Picks - خودرو بانک
Is Prelude Therapeutics Incorporated stock forming a cup and handle2025 Volume Leaders & Safe Capital Growth Stock Tips - خودرو بانک
Can Prelude Therapeutics Incorporated continue delivering strong returnsJuly 2025 Big Picture & Advanced Technical Analysis Signals - خودرو بانک
Prelude Therapeutics Incorporated stock trend forecastEarnings Overview Summary & Accurate Intraday Trading Signals - Newser
Is now a turning point for Prelude Therapeutics IncorporatedQuarterly Performance Summary & Weekly Breakout Stock Alerts - Newser
How to interpret RSI for Prelude Therapeutics Incorporated stock2025 Buyback Activity & Daily Profit Focused Screening - Newser
Will Prelude Therapeutics Incorporated outperform the marketMarket Rally & Verified Chart Pattern Signals - Newser
How to manage a losing position in Prelude Therapeutics IncorporatedWeekly Profit Summary & Verified Entry Point Detection - Newser
What to expect from Prelude Therapeutics Incorporated in the next 30 daysJuly 2025 Earnings & High Win Rate Trade Alerts - Newser
Prelude Therapeutics Incorporated’s volatility index tracking explainedChart Signals & Consistent Profit Alerts - Newser
Real time scanner hits for Prelude Therapeutics Incorporated explainedJuly 2025 Recap & Technical Buy Zone Confirmations - Newser
What MACD signals say about Prelude Therapeutics Incorporated2025 Volatility Report & Weekly High Return Opportunities - Newser
Can Prelude Therapeutics Incorporated reach resistance levels soon2025 Buyback Activity & Fast Momentum Entry Tips - خودرو بانک
Market Rankings: What drives Prelude Therapeutics Incorporated’s stock priceInsider Selling & Weekly Watchlist of Top Performers - خودرو بانک
How sentiment analysis helps forecast Prelude Therapeutics IncorporatedWatch List & Consistent Growth Equity Picks - Newser
Evaluating Prelude Therapeutics Incorporated with trendline analysisJuly 2025 Big Picture & Risk Controlled Daily Plans - Newser
Visual trend scoring systems applied to Prelude Therapeutics Incorporated2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
Detecting price anomalies in Prelude Therapeutics Incorporated with AIJobs Report & Free Community Consensus Stock Picks - Newser
Quantitative breakdown of Prelude Therapeutics Incorporated recent moveQuarterly Earnings Report & Risk Managed Investment Strategies - Newser
Is Prelude Therapeutics Incorporated backed by strong institutional buyingJuly 2025 Movers & Daily Volume Surge Trade Alerts - خودرو بانک
Real time social sentiment graph for Prelude Therapeutics IncorporatedEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Prelude Therapeutics Incorporated stock outlook for YEAR2025 Macro Impact & Daily Stock Momentum Reports - Newser
Does Prelude Therapeutics Incorporated fit your quant trading modelEarnings Recap Report & Daily Growth Stock Tips - Newser
Does Prelude Therapeutics Incorporated meet Warren Buffett’s criteriaWeekly Investment Summary & Daily Stock Momentum Reports - خودرو بانک
Investment Review: What drives Prelude Therapeutics Incorporated’s stock priceWeekly Risk Report & Smart Swing Trading Alerts - خودرو بانک
Prelude Therapeutics Incorporated stock volume spike explained2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Can Prelude Therapeutics Incorporated keep up with sector leadersWeekly Trading Summary & Daily Volume Surge Signals - خودرو بانک
Prelude Therapeutics Inc (PRLD) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):